25 February 2021: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announces the appointment of Allenby Capital Limited (“Allenby”) as joint corporate broker, with immediate effect to work alongside the Company’s existing nominated adviser and joint broker, Stifel Nicolaus Europe Limited.